Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin

Not Applicable

Completed

• Conditions: Vitamin B12 Deficiency; Neuropathy; Type 2 Diabetes; Anemia
• Interventions: Behavioral: Office visit intervention; Behavioral: Electronic Message Intervention

• Registration Number: NCT02076347
• Lead Sponsor: Ohio State University

Brief Summary

The purpose of this project is to compare two pharmacist-led population management strategies designed to increase the rate of appropriate monitoring of vitamin B12 and serum creatinine for patients taking metformin.

Detailed Description

Not available

Study Timeline

• Study Start: 2014-02
• Study First Submitted: 2014-02-26
• Study First Submitted QC: 2014-02-27
• Study First Posted: 2014-03-03
• Primary Completion: 2014-08
• Status Verified: 2015-10
• Study Completion: 2015-10
• Last Update Submitted: 2015-10-15
• Last Update Posted: 2015-10-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 489

Inclusion Criteria

• On Metformin for at least one year
• Activated patient portal for electronic messaging
• Patient of an attending physician at Ohio State General Internal Medicine
• No serum vitamin B12 and/or no serum creatinine measurement in the past year

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Office visit-based intervention	Office visit intervention	-
Electronic message-based intervention	Electronic Message Intervention	-

Primary Outcome Measures

Name	Time	Method
Percentage of patients in each arm who obtain monitoring of vitamin B12 as recommended	6 months

Secondary Outcome Measures

Name	Time	Method
Number of patients with newly identified vitamin B12 deficiency	6 months
Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of anemia upon chart review	within 6 months	When a patient's serum vitamin B12 level comes back and is low the chart will be reviewed immediately to determine this. This could happen anytime during the 6 month study period.
Percentage of patients with newly identified vitamin B12 deficiency who have prior evidence of neuropathy upon chart review	within 6 months	When a patient's serum vitamin B12 level comes back and is low the chart will be reviewed immediately to determine if neuropathy is also listed as a medical problem. This could happen anytime during the 6 month study period.

Trial Locations

Locations (1)

The Ohio State University General Internal Medicine; 🇺🇸 Columbus, Ohio, United States